Bristol Myers Squibb Announces Dividend

NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of forty-nine cents ($0.49) per share on the $.10 par value common stock of the company. The dividend is payable on November 1, 2021 to stockholders of record at the close of business on October 1, 2021.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable December 1, 2021 to stockholders of record at the close of business on November 9, 2021.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20210909005993/en/

Media:
[email protected]

Investors:
Nina Goworek, 908-673-9711, [email protected]
Karen Wheeler, 609-252-3396, [email protected]

Source: Bristol Myers Squibb

You May Also Be Interested In

• OKX Card Usage Surges Across Europe as Crypto Moves Into Everyday Spending
• Jyske Realkredit explores the possibilities of issuing a new euro denominated benchmark covered bond
• Chainlink Price Prediction Grinds at $9 While Pepeto’s Burn Engine Races Toward a Listing